异动解读 | 荣昌生物盘中大跌5.91%,创新药板块承压

异动解读
19 Jun

港股荣昌生物(09995.HK)今日盘中大跌5.91%,引发市场关注。截至11时45分,该股报49.05港元/股,成交量525.2万股,换手率2.52%,振幅高达9.58%。

数据显示,荣昌生物今日资金流出1.1186亿港元,超过流入的1.04556亿港元,呈现净流出状态。值得注意的是,该股近期表现波动较大。最新财报显示,公司实现营业收入5.70亿港元,净利润为-2.75亿港元,每股收益-0.50港元,市盈率为-17.43倍。

分析人士指出,荣昌生物股价下跌可能与整体生物技术行业承压有关。尽管近期中央多部门加大对创新药的支持力度,如优化集采措施等,但市场对创新药企业的盈利前景仍存在担忧。另一方面,部分创新药企业近期频繁进行融资活动,如恒瑞医药、科伦博泰生物等,这可能引发投资者对行业资金压力的担忧。此外,市场情绪波动也可能是导致荣昌生物股价下跌的因素之一。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10